GLP-1 receptor agonists are designed to regulate blood sugar levels and reduce hunger signals in the body, which could lead to eating less and helping with long-term weight management
(Id also first consider CIRS and MSH levels for gut health first)
Common side effects may include nausea, vomiting, diarrhea or constipation, particularly when doses are increased
Facial Volume Loss: Research indicates about 7% mid-facial volume loss per 10 kg of weight loss in GLP-1 patients, which may reduce the skin's natural "cushion" against UV
However, dietary adjustments, proper hydration, and gradual dose increases accelerate this process significantly
The Styku is a 3D camera that scans the body and precisely calculates: Body fat percentage Muscle mass percentage Bone mass percentage Visceral fat It also measures the circumference of many locations on the body, such as the: Chest Waist Hip Thigh Calf Neck Arm The Styku scan gives patients an instant visual demonstration of their weight loss and shows all the other important metrics involved, beyond just the number on the scale